.png)
CoreX is the UAE's sovereign Bio-AI intelligence engine guiding pharma into the next generation of medicine & enabling population-scale precision.
Three Bio-AI-driven capabilities transforming how medicine is designed, delivered, and discovered.
Validated by Global Pharmaceutical Leaders
CoreX has undergone multi-year blinded evaluations with several of the world’s largest pharmaceutical companies. Across these independent studies, the platform consistently outperformed legacy preclinical systems in predicting human drug safety.
Key outcomes include:
• 92% accuracy in blinded liver toxicity prediction
• 87% specificity / 75% sensitivity across FDA-classified compounds
• Correct prediction of Phase 1 & Phase 3 failures
• Differentiation of toxic vs safe structural analogs
Top 5 Global Pharma
Evaluation on clinical-stage drug candidates
Global Pharma Leader
Portfolio-wide toxicity assessment
Top 10 Global Pharma Evaluation on clinical-stage drug candidates
_edited.png)
“Merck: This is
the Holy Grail”
“AI drug discovery companies to watch”
“World’s most
innovative companies”
COMPANY OF THE YEAR 2024 IN DRUG SAFETY AND LONGEVITY
"ChatGPT and other LLM foundational models have transformed our lives, impacting most industries. This foundational Model now has the potential to similarly revolutionize longevity and healthcare.”
One Engine. Three Bio-AI Capabilities.
Three Bio-AI pillars that reduce cost, amplify precision, and convert human biology into measurable healthcare and economic impact.
Drug Development
Where discovery accelerates and failure rates collapse. Bio-Avatars predict safety and efficacy before trials — cutting preclinical failure by up to 70% and shrinking timelines from years to weeks.
Precision meets performance. We evolve existing drugs — optimizing dosing and popn-specific formulations to boost efficacy by 20–40% and cut ADEs by up to 60%.
Pharma Services
BioData Engine
Where every experiment strengthens intelligence.
Each result feeds the world’s most advanced PK dataset — accelerating approvals, lowering trial costs, and turning biology into an economic asset.
An actual tiny cardiac model in our lab beats on its own, mirroring the response of it's donor individual, allowing us to test drugs without harming anyone.
Unlocking Years of Vitality
CoreX's Bio-AI engine reawakens medicine’s full potential —turning existing drugs into precision health tools, and transforming lifespan into healthspan.
1B+
Years of vitality regained each generation
12-15
Years gained in healthspan
30%-
50%
Increase in treatment efficacy
>90%
Representation of national demographics in drug development
01
Bio-AI Platform
We spent 5 years and US60M building CoreX’s proprietary artificial intelligence trained not on data from literature, but on life itself. It reads the biological language of living cells and organoids — predicting human response before clinical trials. MORE
UAE's Bio-Intelligence Engine
Innovation at CoreX is not built in isolation — it’s born at the intersection of biology, intelligence, and nation. Each breakthrough strengthens a sovereign ecosystem where science serves life, and life teaches science.
02
Population-on-Chip
A living, continuously expanding biobank of iPSC-derived organoids representing real populations.
PBLO powers population-specific medicine and sovereign pharmacoequity — ensuring every therapy is optimized for the people it serves. Open source for sovereign users. MORE
03
PK Index
A new global benchmark for pharmacokinetic validation. By modeling drug absorption, metabolism, and toxicity using Bio-Avatars, the PK Index sets a new standard for generics equivalency and safety before human exposure. MORE
_edited.png)
CoreX for the Individual
Where the power of CoreX meets personal longevity.
LifeX enables individuals to biobank their own cells, generate Bio-Avatars, and participate in the future of regenerative medicine and preventive health. MORE
